Tekla Capital Management’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

Tekla Capital Management’s Portfolio HARP Stock Details HARP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$185K	Hold	25,991	–	–	0.01%	155
2023 Q1	$193K	Hold	25,991	–	–	0.01%	165
2022 Q4	$189K	Hold	25,991	–	–	0.01%	162
2022 Q3	$252K	Hold	25,991	–	–	0.01%	157
2022 Q2	$496K	Hold	25,991	–	–	0.02%	152
2022 Q1	$1.29M	Buy	+25,991	New	+$1.35M	0.05%	137
2021 Q1	–	Sell	-10,642	Closed	-$1.77M	–	221
2020 Q4	$1.77M	Hold	10,642	–	–	0.06%	163
2020 Q3	$1.81M	Buy	+10,642	New	+$1.53M	0.07%	161

Other funds holding HARP

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

LPC

Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Tekla Capital Management's HARP Position: Q2 2023 in Review

Tekla Capital Management held its Harpoon Therapeutics, Inc. Common Stock (HARP) position steady in Q2 2023 at 25,991 shares worth $185K. The position accounts for 0.01% of the portfolio, ranked #155.

Tekla Capital Management first reported a position in HARP in Q3 2020 and has held it in 8 quarters since. The position peaked at $1.81M in Q3 2020. 44 funds tracked by Wall St. Rank hold HARP as of Q2 2023.

Tekla Capital Management held 25,991 shares of Harpoon Therapeutics, Inc. Common Stock worth $185K as of Q2 2023.
Tekla Capital Management left its Harpoon Therapeutics, Inc. Common Stock share count unchanged in Q2 2023.
Harpoon Therapeutics, Inc. Common Stock made up 0.01% of Tekla Capital Management's portfolio in Q2 2023, its #155 holding.
Tekla Capital Management first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q3 2020 and has held it in 8 quarters since.
Tekla Capital Management's Harpoon Therapeutics, Inc. Common Stock position peaked at $1.81M in Q3 2020.
44 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q2 2023.

Based on Tekla Capital Management's 13F filing for Q2 2023, filed 10 Aug 2023.